標(biāo)題: Titlebook: Gastrointestinal Malignancies; A Practical Guide on Suzanne Russo,Sarah Hoffe,Edward Kim Book 2018 Springer International Publishing AG 201 [打印本頁] 作者: 嬉戲 時(shí)間: 2025-3-21 19:31
書目名稱Gastrointestinal Malignancies影響因子(影響力)
作者: 責(zé)任 時(shí)間: 2025-3-21 20:15 作者: Oratory 時(shí)間: 2025-3-22 01:52
Gastric Cancer (Siewert Type III)urgical series from experienced, high-volume centers, 5-year overall survival following extended surgical resections is generally less than 60%. As such, numerous studies have investigated the use of neoadjuvant or adjuvant therapies with chemotherapy, radiation, or concurrent chemoradiotherapy to i作者: Vertebra 時(shí)間: 2025-3-22 05:36 作者: 使人入神 時(shí)間: 2025-3-22 10:29
Gallbladder Cancer and Extrahepatic Cholangiocarcinoma of metastatic disease. Adjuvant chemoradiation following surgery has demonstrated benefit in multiple retrospective studies and is generally recommended for advanced T-stage, node-positive, or margin-positive disease. Definitive chemoradiation is used in patients with unresectable non-metastatic di作者: minion 時(shí)間: 2025-3-22 16:48
Non-Colorectal Liver Metastaseschniques, local treatment of isolated liver lesions in the appropriate clinical scenario has the potential to extend life and decrease morbidity from disruption of liver function. While this has primarily been studied in colorectal metastases, the same principles are now being shown to apply in mult作者: minion 時(shí)間: 2025-3-22 17:04
Proton Beam Therapy for Hepatic Malignanciesto its dosimetric advantages in sparing normal liver tissue from radiation. In this chapter, the rationale for using PBT for liver cancer patients, treatment planning and delivery including special considerations specific to PBT, and toxicities of liver PBT are discussed.作者: 雀斑 時(shí)間: 2025-3-22 21:22
Resectable and Borderline Resectable Pancreatic Cancer by adjuvant treatments results in disappointing outcomes. Neoadjuvant therapy has several potential advantages over adjuvant therapy including earlier delivery of systemic treatment, in vivo assessment of response, increased resectability rate in borderline resectable patients, and increased margin作者: 形容詞 時(shí)間: 2025-3-23 01:51 作者: 食品室 時(shí)間: 2025-3-23 07:52 作者: 盟軍 時(shí)間: 2025-3-23 11:18 作者: 身心疲憊 時(shí)間: 2025-3-23 16:56
Colorectal Cancer Liver Metastasese of radiation has largely been due to the availability of surgery and percutaneous thermal ablation therapies, as well as the relative radiosensitivity of the liver. Technological advances in treatment planning and radiation delivery have enabled the safe and effective application of hypofractionat作者: infarct 時(shí)間: 2025-3-23 21:37
Carcinoma of the?Anal Canaln the definitive management of squamous cell carcinoma of the anal canal. Despite the favorable disease-free survival with this organ-preserving approach, chemoradiation is associated with significant acute and late side effects. Moreover, local and distant failure remains a challenge in patients wi作者: 迅速成長 時(shí)間: 2025-3-24 01:02
https://doi.org/10.1007/978-94-009-8165-2geal cancers are locally and/or regionally advanced at the time of presentation. Histologically, cervical esophageal cancers are most likely to be squamous cell carcinoma. Due to proximity to critical organs, they are often not amenable to surgery and are usually managed similarly to locally advance作者: callous 時(shí)間: 2025-3-24 05:14 作者: FRAX-tool 時(shí)間: 2025-3-24 07:48 作者: 打火石 時(shí)間: 2025-3-24 13:08
Free Particle Motion in Three Dimensions,nding of the dose-volume tolerances of the liver have changed this. External beam radiation, such as stereotactic body radiation therapy, intensity-modulated radiation therapy, and proton therapy can be used to deliver high doses to liver tumors while sparing other organs. Radiation, including exter作者: FLOUR 時(shí)間: 2025-3-24 16:33 作者: jovial 時(shí)間: 2025-3-24 19:44 作者: Mhc-Molecule 時(shí)間: 2025-3-25 01:31 作者: sclera 時(shí)間: 2025-3-25 03:25
Grounded Theory Methodologie (GTM), by adjuvant treatments results in disappointing outcomes. Neoadjuvant therapy has several potential advantages over adjuvant therapy including earlier delivery of systemic treatment, in vivo assessment of response, increased resectability rate in borderline resectable patients, and increased margin作者: 輕信 時(shí)間: 2025-3-25 11:14
Interaktion und Organisationsberatungh localized pancreatic cancer present with locally advanced disease. Currently, there is no consensus for optimal treatment of locally advanced pancreatic cancer. There has been much debate and controversy with regard to the best upfront treatment modality (chemotherapy and radiotherapy), sequencing作者: Angiogenesis 時(shí)間: 2025-3-25 15:09
https://doi.org/10.1007/978-3-658-36189-1tes. The primary treatment modality for colon cancer is surgery, with extent determined by tumor location, patient anatomy, and clinical considerations. Adjuvant chemotherapy is the standard of care for lymph node positive (stage III) disease, given established survival benefit. IORT is used to decr作者: 道學(xué)氣 時(shí)間: 2025-3-25 18:44
https://doi.org/10.1007/978-3-322-93559-5tment of these tumors. The location, size, and depth of invasion of the primary tumor help to determine the appropriate surgical technique. For patients with rectal cancer, small minimally invasive T1 lesions can be considered for local excision. All other lesions are typically resected via low ante作者: 緊張過度 時(shí)間: 2025-3-25 20:22 作者: CHASE 時(shí)間: 2025-3-26 02:16 作者: OATH 時(shí)間: 2025-3-26 07:09 作者: DOSE 時(shí)間: 2025-3-26 11:50
https://doi.org/10.1007/978-3-642-87115-3sease. This chapter outlines treatment planning approaches for adjuvant and definitive radiation as a component of multimodality therapy for patients with non-metastatic gallbladder cancer and extrahepatic cholangicarcinoma.作者: 我還要背著他 時(shí)間: 2025-3-26 13:44
Interaktionale Sprache und Prosodie,ed radiation treatments to liver tumors, including patients with colorectal cancer liver metastases. In this chapter, I discuss current clinical practice regarding the management of colorectal cancer liver metastases as well as practical details of treatment planning.作者: DEAWL 時(shí)間: 2025-3-26 19:49
Gallbladder Cancer and Extrahepatic Cholangiocarcinomasease. This chapter outlines treatment planning approaches for adjuvant and definitive radiation as a component of multimodality therapy for patients with non-metastatic gallbladder cancer and extrahepatic cholangicarcinoma.作者: 多樣 時(shí)間: 2025-3-26 22:20 作者: sorbitol 時(shí)間: 2025-3-27 02:53 作者: 跑過 時(shí)間: 2025-3-27 07:21 作者: extemporaneous 時(shí)間: 2025-3-27 11:32 作者: GLADE 時(shí)間: 2025-3-27 14:46 作者: laxative 時(shí)間: 2025-3-27 18:26
Carcinoma of the?Anal Canaltensification of therapy in high-risk disease. This chapter will provide a detailed description of modern radio-chemotherapy delivery approaches for the treatment of anal canal cancer with an emphasis on practical considerations for the clinician.作者: 埋伏 時(shí)間: 2025-3-28 00:09 作者: 違抗 時(shí)間: 2025-3-28 03:23 作者: 車床 時(shí)間: 2025-3-28 08:42 作者: Colonoscopy 時(shí)間: 2025-3-28 10:39 作者: GLUT 時(shí)間: 2025-3-28 17:13
Proximal/Cervical Esophageal Cancer resection, with lesser functional impairment and better quality of life. Radiation techniques have improved tremendously over the past several decades, resulting in less acute and late complications. This chapter provides a practical guide for evidence and treatment planning considerations for proximal/cervical esophageal cancers.作者: certitude 時(shí)間: 2025-3-28 21:50
Gastric Cancer (Siewert Type III)adjuvant chemoradiation have both demonstrated significant improvements in OS, even following maximal surgical resection. This chapter provides a guide for utilizing radiotherapy-containing regimens for the adjuvant treatment of gastric cancers.作者: 起皺紋 時(shí)間: 2025-3-29 02:30 作者: 退出可食用 時(shí)間: 2025-3-29 03:42 作者: originality 時(shí)間: 2025-3-29 09:05
978-3-319-64899-6Springer International Publishing AG 2018作者: 干涉 時(shí)間: 2025-3-29 12:23 作者: paradigm 時(shí)間: 2025-3-29 19:31
I. Brintzinger-von K?ckritz,U. Thurnerto its dosimetric advantages in sparing normal liver tissue from radiation. In this chapter, the rationale for using PBT for liver cancer patients, treatment planning and delivery including special considerations specific to PBT, and toxicities of liver PBT are discussed.作者: lymphoma 時(shí)間: 2025-3-29 21:50
Proton Beam Therapy for Hepatic Malignanciesto its dosimetric advantages in sparing normal liver tissue from radiation. In this chapter, the rationale for using PBT for liver cancer patients, treatment planning and delivery including special considerations specific to PBT, and toxicities of liver PBT are discussed.作者: 認(rèn)為 時(shí)間: 2025-3-30 00:57
Suzanne Russo,Sarah Hoffe,Edward KimExplains how to incorporate quality radiation therapy in multimodality treatment of gastrointestinal malignancies.Assesses the safety and efficacy of radiotherapy in combination with systemic agents, 作者: CLAN 時(shí)間: 2025-3-30 07:54 作者: daredevil 時(shí)間: 2025-3-30 10:50 作者: inspiration 時(shí)間: 2025-3-30 14:35
